FPIA is a monocarboxylate; in studies by Mashimo [16], it was posited that the monocarboxylate, acetate, is used by primary brain tumours and IMD alike for growth in preference to glucose, and that the enzyme ACSS2, might be responsible for the adaption of cancers to grow in this niche. This evidence concerns the gene ACSS2 and brain neoplasm.